Division of Gastroenterology and Hepatology, Department of Medical Sciences, A.O. Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, Turin I-10126, Italy.
Division of Gastroenterology and Hepatology, Department of Medical Sciences, A.O. Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, Turin I-10126, Italy.
Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24.
Liver-related mortality is the third cause of death in patients with nonalcoholic fatty liver disease, but the long-term prognosis basically depends on the presence and severity of liver damage. Thus, life expectancy in patients with simple steatosis is not different from the general population, but liver-related mortality is significantly higher in patients with nonalcoholic steatohepatitis (NASH), particularly in those with advanced fibrosis. Progression of liver disease is observed in up to one-third of patients with NASH. The long-term hepatic prognosis mostly depends on the histologic stage at initial liver biopsy, but multiple risk factors may concur.
肝脏相关死亡率是非酒精性脂肪性肝病患者的第三大死因,但长期预后基本取决于肝脏损伤的存在和严重程度。因此,单纯性脂肪变性患者的预期寿命与普通人群无差异,但非酒精性脂肪性肝炎(NASH)患者的肝脏相关死亡率显著更高,尤其是纤维化程度较高的患者。多达三分之一的 NASH 患者的肝脏疾病会进展。长期肝脏预后主要取决于初次肝活检的组织学分期,但可能存在多种危险因素。